Amedisys (AMED) Tops Q1 EPS by 2c; Guides
AMED Hot Sheet
Revenue Growth %: +1.8%Financial Fact:
Operating expenses: 358.38M
Today's EPS Names:
VSNT, CIM, KH, More
Amedisys Inc. (Nasdaq: AMED) reports Q1 EPS of $0.99, 2 cents better than the analyst estimate of $0.97. Revenue for the quarter was $341.8 million, versus the consensus of $345.5 million.
Amedisys sees FY09 EPS of $4.10-$4.30, verus the consensus of $4.18.
Get Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Flowers Foods, Inc. (FLO) Reports In-Line Q1 EPS; Adjusts FY12 EPS Growth Outlook
- PVH Corp. (PVH) Tops Q1 EPS by 4c; Guides FY12 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
